FI
Fady Ibraham Malik sold $215K of CYTK stock
Fady Ibraham Malik, EVP Research & Development of Cytokinetics Inc (CYTK), sold 3,500 shares of CYTK stock worth $215K, per an SEC Form 4 filed Oct 6, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Oct 6, 2026.
CYTK has moved -8.5% since the trade date, from $61.35 to $56.13 (Nov 13, 2026 close).
- Traded
- Oct 6, 2026
- Disclosed
- Oct 6, 2026
- Filing delay
- 0 days
- Price since
- -8.5%
- Role
- EVP Research & Development
- Source
- SEC Form 4